N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Volume 117, Article 110550, Year 2022